Cargando…
Novel myosin-based therapies for congenital cardiac and skeletal myopathies
The dysfunction in a number of inherited cardiac and skeletal myopathies is primarily due to an altered ability of myofilaments to generate force and motion. Despite this crucial knowledge, there are, currently, no effective therapeutic interventions for these diseases. In this short review, we disc...
Autores principales: | Ochala, Julien, Sun, Yin-Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099184/ https://www.ncbi.nlm.nih.gov/pubmed/27412953 http://dx.doi.org/10.1136/jmedgenet-2016-103881 |
Ejemplares similares
-
Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry‐Based Study
por: Espinosa‐Ortega, Fabricio, et al.
Publicado: (2022) -
Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies
por: Qin, Li, et al.
Publicado: (2021) -
Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors
por: Armanini, Decio, et al.
Publicado: (2021) -
Modulating myosin restores muscle function in a mouse model of nemaline myopathy
por: Lindqvist, Johan, et al.
Publicado: (2016) -
Nemaline Myopathy-Related Skeletal Muscle α-Actin (ACTA1) Mutation, Asp286Gly, Prevents Proper Strong Myosin Binding and Triggers Muscle Weakness
por: Ochala, Julien, et al.
Publicado: (2012)